Cargando…
Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
Despite an ever-growing prevalence and increasing economic burden of Alzheimer’s disease (AD) and Parkinson’s disease (PD), recent advances in drug development have only resulted in minimally effective treatment. In AD, along with amyloid and tau phosphorylation, there is an associated increase in i...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812772/ https://www.ncbi.nlm.nih.gov/pubmed/36258018 http://dx.doi.org/10.1038/s41380-022-01792-4 |